<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Habib Ganfon</style></author><author><style face="normal" font="default" size="100%">Axel Ahouansou</style></author><author><style face="normal" font="default" size="100%">Celia Dechavanne</style></author><author><style face="normal" font="default" size="100%">Callinice Capo-Chichi</style></author><author><style face="normal" font="default" size="100%">Latifou Lagnika</style></author><author><style face="normal" font="default" size="100%">Agnes Aubouy</style></author><author><style face="normal" font="default" size="100%">Sebastien Dechavanne</style></author><author><style face="normal" font="default" size="100%">Achille Massougbodji</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Cytotoxic Activity of Annona Muricata L, Momordica Charantia L. and Launaea Taraxacifolia Willd. from Benin: A Flow Cytometric Approach</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Benin</style></keyword><keyword><style  face="normal" font="default" size="100%">Cancer</style></keyword><keyword><style  face="normal" font="default" size="100%">Cytotoxicity</style></keyword><keyword><style  face="normal" font="default" size="100%">Plant extracts</style></keyword><keyword><style  face="normal" font="default" size="100%">selectivity</style></keyword><keyword><style  face="normal" font="default" size="100%">THP-1 cells</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2025</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2025</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">17</style></volume><pages><style face="normal" font="default" size="100%">727-732</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Cancer is rising worldwide, causing approximately 9.7 million deaths in 2022. Treatments are costly, have significant side effects, and are sometimes unavailable in Benin. Medicinal plants offer promising avenues for new therapeutic agents. &lt;strong&gt;Objective: &lt;/strong&gt;This study uses flow cytometry method to evaluate the cytotoxic activity of &lt;em&gt;Annona muricata&lt;/em&gt; (Annonaceae), &lt;em&gt;Momordica charantia&lt;/em&gt; (Cucurbitaceae) and &lt;em&gt;Launaea taraxacifolia&lt;/em&gt; (Asteraceae), three plants from the Beninese pharmacopoeia known for their anti-cancer properties. &lt;strong&gt;Materials and Methods:&lt;/strong&gt; The leaves of A. muricata, &lt;em&gt;L. taraxacifolia &lt;/em&gt;and whole plants of &lt;em&gt;M. charantia&lt;/em&gt; were collected in southern Benin. Extracts were prepared by aqueous decoction and sequential extraction with solvents of increasing polarity (dichloromethane, ethyl acetate, methanol). The phytochemical profiles of the extracts were determined using TLC and tube tests. The cytotoxicity of the extracts was evaluated on THP-1 cancer cells and PBMC healthy cells. After treatment with the extracts, cell viability was measured by flow cytometry after staining with Thiazole Orange and Hoechst 33258. &lt;strong&gt;Results:&lt;/strong&gt; The dichloromethane extracts of &lt;em&gt;A. muricata&lt;/em&gt; and &lt;em&gt;M. charantia&lt;/em&gt;, and the ethyl acetate extract of &lt;em&gt;M. charantia&lt;/em&gt; and&lt;em&gt; L. taraxacifolia &lt;/em&gt;showed significant cytotoxic effects on THP-1 cells. Their half-maximal inhibitory concentrations (IC&lt;sub&gt;50&lt;/sub&gt;) were 139.6 μg/mL, 72.89 μg/mL, 81.88 μg/mL and 106.3 μg/ mL, respectively. These extracts also demonstrated good selectivity toward normal cells. Phytochemical screening revealed the presence of alkaloids, coumarins, flavonoids, anthracene glycosides and triterpenes in the active extracts. &lt;strong&gt;Conclusion:&lt;/strong&gt; This study demonstrated the cytotoxic potential of three medicinal plants from the Beninese pharmacopoeia which may serve to develop further new anticancer therapies.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">727</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Habib Ganfon&lt;sup&gt;1*&lt;/sup&gt;, Axel Ahouansou&lt;sup&gt;1,2,3,4&lt;/sup&gt;, Célia Dechavanne&lt;sup&gt;2,5&lt;/sup&gt;, Callinice Capo- Chichi&lt;sup&gt;3&lt;/sup&gt;, Latifou Lagnika&lt;sup&gt;4&lt;/sup&gt;, Agnès Aubouy&lt;sup&gt;2,6&lt;/sup&gt;, Sébastien Dechavanne&lt;sup&gt;2,5&lt;/sup&gt;, Achille Massougbodji&lt;sup&gt;2&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Laboratoire de Pharmacognosie et Phytothérapie du Centre de Recherche et de Développement du Médicament (CRDM-PharmaLab), 01 BP 188, Université d’Abomey-Calavi (UAC), BENIN&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Institut de Recherche Clinique du Benin (IRCB), 04 BP 1114, Abomey-Calavi, BENIN&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Laboratoire de recherche sur les Biomarqueurs Moléculaires en Cancérologie et en Nutrition, Unité de Biochimie et Biologie Moléculaire UAC, BENIN&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Laboratoire de Biologie Intégrative pour l’Innovation Thérapeutique, Unité de Biochimie et des Substances Naturelles Bioactives, UAC, BENIN&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;IRD, Inserm, MERIT, Université Paris Cité, F-75006 Paris, FRANCE&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;6&lt;/sup&gt;UMR 152 PHARMADEV, IRD, Université de Toulouse, FRANCE&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Puja Adi Priatna</style></author><author><style face="normal" font="default" size="100%">Retno Widyowati</style></author><author><style face="normal" font="default" size="100%">Sukardiman</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Cytotoxic Potential of Mitragyna speciosa as Anticancer - A Review</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Alkaloids</style></keyword><keyword><style  face="normal" font="default" size="100%">Cancer</style></keyword><keyword><style  face="normal" font="default" size="100%">Cytotoxicity</style></keyword><keyword><style  face="normal" font="default" size="100%">M. speciosa</style></keyword><keyword><style  face="normal" font="default" size="100%">Mitragynine</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">1418-1423</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;Herbal treatment has been proposed and researched as an alternative to cancer treatment. One of the reasons contains compounds that have cytotoxic effects. Mitragyna speciosa are known to contain alkaloids and have a cytotoxic effect. &lt;strong&gt;Objective: &lt;/strong&gt;This review aimed to provide information about preclinical studies and investigates the cytotoxicity or anticancer activity of &lt;em&gt;M. speciosa.&lt;/em&gt; &lt;strong&gt;Methods&lt;/strong&gt;: Search articles through PubMed, Springer, and Science Direct databases focusing on preclinical trials according to PRISMA guidelines. A database search yielded a total of 206 identifiable studies. Then duplicate removal and feasibility screening were carried out, resulting in 11 studies that were eligible for final analysis. &lt;strong&gt;Results:&lt;/strong&gt; The anticancer potentials reviewed in this study include Neuroblastoma, Leukemia, Colon Cancer, Breast Cancer, Kidney &amp;amp; Liver Cytotoxicity, Glutathione Transferases Metabolizing Enzymes, Alkaloid Combination of &lt;em&gt;M. speciosa&lt;/em&gt; &amp;amp; Cisplatin, Alkaloid Combination of M. speciosa &amp;amp; Doxorubicin and Mutagenic-Antimutagenic Activity of &lt;em&gt;M. speciosa&lt;/em&gt;. Extracts and dominant alkaloids of &lt;em&gt;M. speciosa&lt;/em&gt; have the potential for anticancer neuroblastoma, leukemia, colon, lung and breast cancer. Based on the safety aspect of the mitragynine compound, there is no mutagenic effect on cells. &lt;strong&gt;Conclusion: &lt;/strong&gt;&lt;em&gt;M. speciosa&lt;/em&gt; contains the dominant active alkaloid compound, mitragynine. Extracts and alkaloids dominant in &lt;em&gt;M. speciosa&lt;/em&gt; have the potential as an anticancer.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Review Article</style></work-type><section><style face="normal" font="default" size="100%">1418</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Puja Adi Priatna&lt;sup&gt;1&lt;/sup&gt;, Retno Widyowati&lt;sup&gt;2&lt;/sup&gt;, Sukardiman&lt;sup&gt;2*&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Airlangga University, Faculty of Pharmacy, Doctor Program of Pharmaceutical Sciences, 60115, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Airlangga University, Faculty of Pharmacy, Department of Pharmaceutical Sciences, 60115, Surabaya, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Carla Y. Requejo-Rodríguez</style></author><author><style face="normal" font="default" size="100%">Elmer M. Roncal-Alayo</style></author><author><style face="normal" font="default" size="100%">Carmen R. Silva-Correa</style></author><author><style face="normal" font="default" size="100%">Víctor E. Villarreal-La Torre</style></author><author><style face="normal" font="default" size="100%">William A. Sagástegui-Guarniz</style></author><author><style face="normal" font="default" size="100%">William A. Sagástegui-Guarniz</style></author><author><style face="normal" font="default" size="100%">Walter E. Janampa-Castillo</style></author><author><style face="normal" font="default" size="100%">José E. Alvarez- Trujillo</style></author><author><style face="normal" font="default" size="100%">Glenda J. Vela-Urbina</style></author><author><style face="normal" font="default" size="100%">Abhel A. Calderón-Peña</style></author><author><style face="normal" font="default" size="100%">Cinthya L. Aspajo-Villalaz</style></author><author><style face="normal" font="default" size="100%">María E. Cotrina-León</style></author><author><style face="normal" font="default" size="100%">Julio A. Castañeda-Carranza</style></author><author><style face="normal" font="default" size="100%">Deivy Y. Dionicio-Rosado</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Juglans regia L.: Source of Bioactive Compounds with Potential Anticancer Activity</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Angiogenesis</style></keyword><keyword><style  face="normal" font="default" size="100%">Antitumor</style></keyword><keyword><style  face="normal" font="default" size="100%">Apoptosis</style></keyword><keyword><style  face="normal" font="default" size="100%">Cancer</style></keyword><keyword><style  face="normal" font="default" size="100%">Juglans regia L.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">October 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">998-1003</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; &lt;em&gt;Juglans regia&lt;/em&gt; L., commonly known as “walnut”, belongs to the Juglandaceae family, with antioxidant, anti-inflammatory, and hypoglycemic medicinal properties. &lt;strong&gt;Objective:&lt;/strong&gt; Describe the anticancer potential of the bioactive compounds present in &lt;em&gt;Juglans regia&lt;/em&gt; L.&lt;strong&gt; Method:&lt;/strong&gt; Recent scientific studies were reviewed on the effects of bioactive compounds from &lt;em&gt;Juglans regia&lt;/em&gt; L. on inhibiting tumor growth and cancer development in several experimental models. To do this, a scientific literature search was carried out, using databases such as PubMed, Scopus, and Science Direct. &lt;strong&gt;Results:&lt;/strong&gt; Regarding the selected articles, it was found that some bioactive compounds from&lt;em&gt; Juglans regia &lt;/em&gt;L. exhibit mechanisms of anticancer action, among which the following stand out: induction of apoptosis, suppression of angiogenesis, and modulation of cell signaling pathways related to cell proliferation and survival. &lt;strong&gt;Conclusion: &lt;/strong&gt;It is concluded that &lt;em&gt;Juglans regia&lt;/em&gt; L. contains active metabolites with potential anticancer effects.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">998</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Carla Y. Requejo-Rodríguez¹, Elmer M. Roncal-Alayo¹, Carmen R. Silva-Correa&lt;sup&gt;2,*&lt;/sup&gt;, Víctor E. Villarreal-La Torre&lt;sup&gt;2&lt;/sup&gt;, William A. Sagástegui-Guarniz&lt;sup&gt;2&lt;/sup&gt;, César D. Gamarra-Sánchez&lt;sup&gt;2&lt;/sup&gt;, Walter E. Janampa-Castillo&lt;sup&gt;3&lt;/sup&gt;, José E. Alvarez-Trujillo&lt;sup&gt;3&lt;/sup&gt;, Glenda J. Vela-Urbina&lt;sup&gt;3&lt;/sup&gt;, Abhel A. Calderón- Peña&lt;sup&gt;4&lt;/sup&gt;, Cinthya L. Aspajo- Villalaz&lt;sup&gt;4&lt;/sup&gt;, María E. Cotrina-León&lt;sup&gt;5&lt;/sup&gt;, Julio A. Castañeda-Carranza&lt;sup&gt;5&lt;/sup&gt;, Deivy Y. Dionicio-Rosado&lt;sup&gt;6&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Escuela de Posgrado, Universidad Nacional de Trujillo, Perú&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Facultad de Farmacia y Bioquímica, Universidad Nacional de Trujillo, Perú&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Facultad de Educación y Ciencias de la Comunicación, Universidad Nacional de Trujillo, Perú&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Facultad de Ciencias Biológicas, Universidad Nacional de Trujillo, Perú.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Facultad de Ciencias Físicas y Matemáticas, Universidad Nacional de Trujillo, Perú.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;6&lt;/sup&gt;Facultad de Ciencias Sociales y Humanidades, Universidad Nacional Ciro Alegría, Perú&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Maylita Sari</style></author><author><style face="normal" font="default" size="100%">Kartika Misalina</style></author><author><style face="normal" font="default" size="100%">M. Yulianto Listiawan</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">The Role of Cyclooxigenase-2 Inhibitor in Basal Cell Carcinoma: A Literature Review</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Basal cell carcinoma.</style></keyword><keyword><style  face="normal" font="default" size="100%">Cancer</style></keyword><keyword><style  face="normal" font="default" size="100%">Chemoprevention</style></keyword><keyword><style  face="normal" font="default" size="100%">Cox-2 inhibitor</style></keyword><keyword><style  face="normal" font="default" size="100%">Cyclooxygenase</style></keyword><keyword><style  face="normal" font="default" size="100%">Skin malignancy</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2023</style></year><pub-dates><date><style  face="normal" font="default" size="100%">March 2023</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">15</style></volume><pages><style face="normal" font="default" size="100%">233-238</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;Basal cell carcinoma (BCC) is the most common skin malignancy worldwide. It has low mortality but can cause significant morbidity primarily due to local destruction. The incidence and associated cost are rising in recent years causing a burden in healthcare system. BCC incidence are continue to increase due to lack of effective chemopreventive option. Several risk factors are associated with the pathogenesis of BCC. One of the major risk factors of BCC is exposure to ultraviolet (UV) rays, hence the prevention strategy for this malignancy include avoidance of natural and artificial sources of UV radiation. However, these methods are still less than optimal in inhibiting the emergence of basal cell carcioma. In recent years, there is accumulating evidence that cyclooxygenase-2 (COX-2), may be involved in the pathogenesis of BCC. Several recent studies have shown that the use of cyclooxygenase-2 (COX-2) inhibitor drugs can prevent the development of nonmelanoma skin tumors including BCC. In this review, we described the potential of COX-2 inhibitors as chemoprevention for BCC.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Review Article</style></work-type><section><style face="normal" font="default" size="100%">233</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Maylita Sari, Kartika Misalina, M. Yulianto Listiawan*&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;Department of Dermatology and Venereology, Universitas Airlangga/ Dr. Soetomo General Academic Teaching Hospital, Surabaya, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ricadonna Raissa</style></author><author><style face="normal" font="default" size="100%">Anna Safitri</style></author><author><style face="normal" font="default" size="100%">Masruri Masruri</style></author><author><style face="normal" font="default" size="100%">Ma Asuncion Guiang Beltran5</style></author><author><style face="normal" font="default" size="100%">Aulanni’am Aulanni’am</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">An In Silico Study of Examining Bioactive Compounds from Azadirachta indica Juss. (Neem) as Potential Death Receptor 5 Inductor in Hepatoma Cells</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Apoptosis</style></keyword><keyword><style  face="normal" font="default" size="100%">Azadirachta indica Juss.</style></keyword><keyword><style  face="normal" font="default" size="100%">Cancer</style></keyword><keyword><style  face="normal" font="default" size="100%">Death receptor 5</style></keyword><keyword><style  face="normal" font="default" size="100%">in silico</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">April 2022</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">14</style></volume><pages><style face="normal" font="default" size="100%">343-349</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;Hepatocellular carcinoma is a disease that occurs due to the uncontrolled growth of abnormal hepatocytes. While cancer cells will not die by itself, due to resistance to death receptors 5 (DR5)-mediated apoptosis. This study is aimed to investigate&lt;em&gt; Azadirachta indica&lt;/em&gt; Juss. leaves compound, such as gedunin and nimbolide, in binding DR5 and stimulated the TNF-related apoptosis inducing ligand (TRAIL), native ligand binding to DR5, which has a role of pro-apoptotic by docking simulation. The ligand and protein preparations were done using Discovery Studio 2016 and Hex 8.0.0 for docking. Visualization was done using Discovery Studio 2016. The docking studies revealed that nimbolide has a lower binding energy with the DR5-TRAIL complex than gedunin. According to the findings, nimbolide is a more effective DR5-TRAIL binding inducer than gedunin and has a higher binding affinity for DR5-TRAIL. This interaction has the potential to significantly reduce DR5-TRAIL binding resistance. Nimbolide and gedunin can be considered as drugs that can sensitize TRAIL binding to DR5 and increase the activation of one of hepar cancers signaling apoptosis pathways.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Research Article </style></work-type><section><style face="normal" font="default" size="100%">343</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Ricadonna Raissa&lt;sup&gt;1&lt;/sup&gt;, Anna Safitri&lt;sup&gt;2,3&lt;/sup&gt;, Masruri Masruri&lt;sup&gt;2&lt;/sup&gt;, Ma Asuncion Guiang Beltran&lt;sup&gt;5&lt;/sup&gt;, Aulanni’am Aulanni’am&lt;sup&gt;2,4&lt;/sup&gt;,&lt;sup&gt;*&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Doctoral Program of Chemistry, Faculty of Mathematics and Natural Science, Universitas Brawijaya, Malang, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Chemistry, Faculty of Mathematics and Natural Science, Universitas Brawijaya, Malang, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Research Center for Smart Molecules of Natural Genetic Resources (SMONAGENES), Universitas Brawijaya, Malang, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Faculty of Veterinary Medicine, Universitas Brawijaya, Malang, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;College of Veterinary Medicine, Tarlac Agricultural University, Camiling, Tarlac, PHILIPPINES.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Carmen R. Silva-Correa</style></author><author><style face="normal" font="default" size="100%">Julio Hilario-Vargas</style></author><author><style face="normal" font="default" size="100%">Víctor E. Villarreal-La Torre</style></author><author><style face="normal" font="default" size="100%">Abhel A. Calderón-Peña</style></author><author><style face="normal" font="default" size="100%">Anabel D. González-Siccha</style></author><author><style face="normal" font="default" size="100%">Cinthya L. Aspajo-Villalaz</style></author><author><style face="normal" font="default" size="100%">José L. Cruzado-Razco</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Potential Anticancer Activity of Bioactive Compounds from Ipomoea batatas</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Antiproliferative</style></keyword><keyword><style  face="normal" font="default" size="100%">Antitumoral.</style></keyword><keyword><style  face="normal" font="default" size="100%">Cancer</style></keyword><keyword><style  face="normal" font="default" size="100%">Sweet potato</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">June 2022</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">14</style></volume><pages><style face="normal" font="default" size="100%">650-659</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;em&gt;Ipomoea batatas&lt;/em&gt; L. (Lam.) known as &quot;sweet potato&quot; is a plant species of great importance in the human diet due to the contribution of nutrients and also for its bioactive compounds that have various medicinal properties. Its anticancer activity is one of the properties that attract the attention of researchers in the study of plant species. This review aims to make a critical compilation of current information on research that evaluated the antitumor and antiproliferative activity of &lt;em&gt;Ipomoea batatas. &lt;/em&gt;The studies included in this review show a diversity of bioactive compounds present in&lt;em&gt; Ipomoea batatas&lt;/em&gt; such as phenolic compounds, anthocyanins, flavonoids, coumarins and sterols; also isolated compounds such as pectin, peptides and glycoproteins that can be related to their biological activity. It is concluded that there are positive results about &lt;em&gt;Ipomoea batatas&lt;/em&gt; and its anticancer activity evaluated through in vitro and &lt;em&gt;in vivo &lt;/em&gt;tests. In humans, safety and efficacy trials are still lacking to support its future use and allow drug development. Further research evaluating the safety and efficacy of reported bioactive compounds in &lt;em&gt;Ipomoea batatas &lt;/em&gt;is important for the development of this promising area.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><accession-num><style face="normal" font="default" size="100%">24</style></accession-num><section><style face="normal" font="default" size="100%">650</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Carmen R. Silva-Correa&lt;sup&gt;1,*&lt;/sup&gt;, Julio Hilario- Vargas&lt;sup&gt;2&lt;/sup&gt;, Víctor E. Villarreal-La Torre&lt;sup&gt;1&lt;/sup&gt;, Abhel A. Calderón-Peña&lt;sup&gt;3&lt;/sup&gt;, Anabel D. González-Siccha&lt;sup&gt;1&lt;/sup&gt;, Cinthya L. Aspajo- Villalaz&lt;sup&gt;3&lt;/sup&gt;, José L. Cruzado-Razco&lt;sup&gt;1&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Facultad de Farmacia y Bioquímica, Universidad Nacional de Trujillo, PERÚ.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Facultad de Medicina, Universidad Nacional de Trujillo, PERÚ. 3Facultad de Ciencias Biológicas, Universidad Nacional de Trujillo, PERÚ.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Andreas Susilo Adi</style></author><author><style face="normal" font="default" size="100%">Berna Elya</style></author><author><style face="normal" font="default" size="100%">Muhammad Hanafi</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Antioxidant and Cytotoxic Bioassay on Blumeodendron toxbrai (Blume.) Stem Bark Hexane, Dichloromethane, and Methanolic Ekstract</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Anticytotoxic DPPH</style></keyword><keyword><style  face="normal" font="default" size="100%">Antioxidant</style></keyword><keyword><style  face="normal" font="default" size="100%">Blumeodendron toksbraii</style></keyword><keyword><style  face="normal" font="default" size="100%">Cancer</style></keyword><keyword><style  face="normal" font="default" size="100%">MCF-7</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style  face="normal" font="default" size="100%">January 2021</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">13</style></volume><pages><style face="normal" font="default" size="100%">139-141</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction:&lt;/strong&gt; &lt;em&gt;Blumeodendron toksbrai&lt;/em&gt;i has the potential to be anti-HIV and anti α-glucosidase. &lt;strong&gt;Objective:&lt;/strong&gt; This research was conducted to examine the effects of antioxidant and cytotoxicity&lt;em&gt; in vitro &lt;/em&gt;from these compounds from methanolic stem bark extract. Method: Stem bark to be extracted with maceration using hexane, dichloromethane, and methanol solution. Extracts were quantified with respect to&lt;em&gt; in vitro&lt;/em&gt; antioxidant activity using the 2.2-diphenyl-1- picrylhydrazyl (DPPH) radical scavenging. Anticytotoxic activity was determined by cytotoxicity assay using MCF-7 cell line with Alamar Blue method.&lt;strong&gt; Results:&lt;/strong&gt; The observed IC&lt;sub&gt;50&lt;/sub&gt; value from hexane, dichloromethane, and methanol extract for antioxidant assay were 88.33 ± 0.19 μg/ mL, 74,54 ± 0,61 μg /mL and 94.1 ± 0.19 μg/mL respectively. IC&lt;sub&gt;50&lt;/sub&gt; value of anti-cytotoxic assay from hexane extract, dichloromethane and methanol extract is 121.24 ± 0.15 μg/mL, 55 ± 0,48 μg/mL and 70.71 ± 0.15 μg/mL. Conclusion: dichloromethane extract showed good promising result for anti-oxidant and cytotoxic assay, futher study needed to isolate compound from this plant.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">139</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Andreas Susilo Adi&lt;sup&gt;1&lt;/sup&gt;,*, Berna Elya&lt;sup&gt;1&lt;/sup&gt;, Muhammad Hanafi, M.Sc&lt;sup&gt;2 &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Faculty of Pharmacy, University of Indonesia, Depok 16424 West Java, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Research Center for Chemistry, Indonesian Institute of Sciences, Kawasan PUSPITEK Serpong, Tangerang Selatan, Banten, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Anirban Chouni</style></author><author><style face="normal" font="default" size="100%">Amrita Pal</style></author><author><style face="normal" font="default" size="100%">Priya K Gopal</style></author><author><style face="normal" font="default" size="100%">Santanu Paul</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">GC-MS Analysis and Screening of Anti-Proliferative Potential of Methanolic Extract of Garcinia cowa on Different Cancer Cell Lines</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Anti-proliferative</style></keyword><keyword><style  face="normal" font="default" size="100%">Cancer</style></keyword><keyword><style  face="normal" font="default" size="100%">Garcinia cowa</style></keyword><keyword><style  face="normal" font="default" size="100%">GC-MS</style></keyword><keyword><style  face="normal" font="default" size="100%">Metabolomic profiling</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style  face="normal" font="default" size="100%">March 2021</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">13</style></volume><pages><style face="normal" font="default" size="100%">347-361</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction:&lt;/strong&gt; &lt;em&gt;Garcinia cowa&lt;/em&gt; (Clusiaceae) is popular among integrative medicine in several communities. This study undertook to evaluate the anti-proliferative activity on cancer cells and its cytotoxic effect on normal cells. Here we are reporting for the first time the metabolomic profiling of &lt;em&gt;G. cowa&lt;/em&gt; leaf. &lt;strong&gt;Methods: &lt;/strong&gt;Anti-proliferative potential of ethyl acetate and methanol extract of &lt;em&gt;Garcinia cowa&lt;/em&gt; leaf assessed by MTT assay. Metabolomic profiling obtained by GC/ MS analysis. Nuclear morphology visualized by DAPI staining. Caspase activation analysed through spectrophotometric assay.&lt;strong&gt; Results:&lt;/strong&gt; The study reveals, that the methanolic extract is more potential in inducing anti-proliferative activity than ethyl acetate extract. Robust antiproliferative activity of the methanolic extract evidenced in lung cancer cell line, A549 followed by MCF–7, HepG2, MOLT – 4, MDA-MB-468 cells. The anti-proliferative effect was negligible in normal PBMC. Further, a dose-dependent increase of nuclear fragmentation visualized in A549 cells treated with the methanolic extract. Post methanolic extract treatment upregulation of caspase-3 and caspase-9 also evidenced in A549 cells. GC/MS analysis revealed the presence of phytoconstituents of different phytochemical groups comprising of 3.45% diterpenoid, 5.45% triterpenoid, 11.24% steroid, 2.03% phytosterol, etc. in methanol extract, as well as 4.53% diterpenoid, 2.88% triterpenoid, 1.09% steroid, 2.11% phytosterol, etc. in ethyl acetate extract with considerable biological importance. &lt;strong&gt;Conclusion:&lt;/strong&gt; This is the maiden report of the metabolomic profiling of leaf extracts of&lt;em&gt; Garcinia cowa&lt;/em&gt; which possess a good repository of potentially bioactive molecules that holds a great promise as a future therapeutic agent in combating lung cancer.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">347</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Anirban Chouni, Amrita Pal, Priya K Gopal, Santanu Paul*&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;Laboratory of Cell and Molecular Biology, Department of Botany, University of Calcutta, 35 Ballygunge Circular Road, Kolkata 700019, West Bengal, INDIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rezi Riadhi Syahdi,</style></author><author><style face="normal" font="default" size="100%">Ayu Annissa</style></author><author><style face="normal" font="default" size="100%">Arry Yanuar</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Virtual Screening of Indonesian Herbal Database for Discovery of Procaspase-3 Activators Using Autodock and Autodock Vina</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Apoptotic</style></keyword><keyword><style  face="normal" font="default" size="100%">Cancer</style></keyword><keyword><style  face="normal" font="default" size="100%">Herbal</style></keyword><keyword><style  face="normal" font="default" size="100%">Procaspase-3 activator</style></keyword><keyword><style  face="normal" font="default" size="100%">Virtual Screening</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2019</style></year></dates><pages><style face="normal" font="default" size="100%">xx-xx</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;&lt;!-- x-tinymce/html --&gt;&lt;strong&gt;Objective:&lt;/strong&gt; Cancer is a disease where body cell grows abnormal, spread to every part of human body. Previous studies have found excessive expression of Procaspase-3 on cancer that must be activated to Caspase-3 to induce apoptotic in cells. &lt;strong&gt;Methods:&lt;/strong&gt; Virtual screening of Indonesian Herbal Database was carried out to discover Procaspase-3 activators. This study was validated using enrichment factor (EF), receiver operating characteristics (ROC) area under curve (AUC) parameters. Among 1412 compounds were screened using Autodock and Autodock Vina software. &lt;strong&gt;Results&lt;/strong&gt;: The virtual screening results using Autodock obtained the best ten compounds with binding energy -8.28 ~ -9.31 kcal/mol and Autodock Vina obtained the best ten compounds with binding energy -8.1 ~ -8.8 kcal/mol. Both virtual screening software showed two compounds in common, i.e., betulinic acid and maslinic acid. &lt;strong&gt;Conclusion:&lt;/strong&gt; Betulinic acid interacts with Leu136A, Lys137A, Tyr195A and Pro201 residues in Autodock and Autodock Vina. While maslinic acid interacts with Leu136A, Lys137A and Pro201 residues in Autodock and Autodock Vina&lt;/p&gt;
</style></abstract><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">xx</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;!-- x-tinymce/html --&gt;&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Rezi Riadhi Syahdi, Ayu Annissa, Arry Yanuar* &lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;Faculty of Pharmacy, Universitas Indonesia, Depok 16424, West Java, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rezi Riadhi Syahdi</style></author><author><style face="normal" font="default" size="100%">Ayu Annissa</style></author><author><style face="normal" font="default" size="100%">Arry Yanuar</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Virtual Screening of Indonesian Herbal Database for Discovery of Procaspase-3 Activators Using Autodock and Autodock Vina</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Apoptotic</style></keyword><keyword><style  face="normal" font="default" size="100%">Cancer</style></keyword><keyword><style  face="normal" font="default" size="100%">Herbal</style></keyword><keyword><style  face="normal" font="default" size="100%">Procaspase-3 activator</style></keyword><keyword><style  face="normal" font="default" size="100%">Virtual Screening</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2019</style></year></dates><volume><style face="normal" font="default" size="100%">xx</style></volume><pages><style face="normal" font="default" size="100%">xx-xx</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Objective:&lt;/strong&gt; Cancer is a disease where body cell grows abnormal, spread to every part of human body. Previous studies have found excessive expression of Procaspase-3 on cancer that must be activated to Caspase-3 to induce apoptotic in cells. &lt;strong&gt;Methods:&lt;/strong&gt; Virtual screening of Indonesian Herbal Database was carried out to discover Procaspase-3 activators. This study was validated using enrichment factor (EF), receiver operating characteristics (ROC) area under curve (AUC) parameters. Among 1412 compounds were screened using Autodock and Autodock Vina software. &lt;strong&gt;Results:&lt;/strong&gt; The virtual screening results using Autodock obtained the best ten compounds with binding energy -8.28 ~ -9.31 kcal/mol and Autodock Vina obtained the best ten compounds with binding energy -8.1 ~ -8.8 kcal/mol. Both virtual screening software showed two compounds in common, i.e., betulinic acid and maslinic acid.&lt;strong&gt; Conclusion:&lt;/strong&gt; Betulinic acid interacts with Leu136A, Lys137A, Tyr195A and Pro201 residues in Autodock and Autodock Vina. While maslinic acid interacts with Leu136A, Lys137A and Pro201 residues in Autodock and Autodock Vina.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">xx</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">xx</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Rezi Riadhi Syahdi, Ayu Annissa, Arry Yanuar&lt;sup&gt;* &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;Faculty of Pharmacy, Universitas Indonesia, Depok 16424, West Java, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Aswathy Jayasree Madanakumar</style></author><author><style face="normal" font="default" size="100%">Murugan Kumaraswamy</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Purified Anthocyanin, its Elicitation from Cell Cultures of Begonia malabarica and Begonia rex-cultorum ‘Baby Rainbow’and it’s In vitro Cytotoxicity Analysis by MTT Assay</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Anthocyanin</style></keyword><keyword><style  face="normal" font="default" size="100%">Begonia</style></keyword><keyword><style  face="normal" font="default" size="100%">Cancer</style></keyword><keyword><style  face="normal" font="default" size="100%">Cell suspension.</style></keyword><keyword><style  face="normal" font="default" size="100%">Cytotoxicity</style></keyword><keyword><style  face="normal" font="default" size="100%">MTT Assay</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style  face="normal" font="default" size="100%">March 2018</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://fulltxt.org/article/523</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">10</style></volume><pages><style face="normal" font="default" size="100%">553-558</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; According to recent statistics, cancer accounts about marked percentage of total deaths in the world, although there are many therapeutic approaches. Unfortunately, the cytotoxicity properties of most chemotherapy drug are nonspecific and therefore do not distinguish between normal healthy cells and tumor cells, these events have led to inappropriate and toxic therapeutic agents with a wide range of side effects. However, several experimental and epidemiological studies have suggested that fruits and vegetables are associated with low risk of various types of cancer. Anthocyanins are natural pigments that provide intense purple to red color in plants. Anthocyanin possess the ability to inhibit oxidative stress and to induce apoptosis in malignant cells, thus may prevent carcinogenesis. &lt;strong&gt;Methods:&lt;/strong&gt; Antiproliferative properties of purified anthocyanin extract from elicited cell suspension cultures of &lt;em&gt;Begonia malabarica&lt;/em&gt; and &lt;em&gt;Begonia rex-cultorum&lt;/em&gt; &amp;lsquo;Baby rainbow&amp;rsquo; was investigated in terms of MTT assay. Anthocyanin extracts were tested for their ability to inhibit the growth of HT29 (colon cancer cells), MG63 (Osteosarcoma), HeLa (Cervical cancer cells) and L929 (Mouse Fibroblast L929) cell lines. &lt;strong&gt;Results:&lt;/strong&gt; Cell viability decreased in a dose dependent manner in all the considered cell lines treated with anthocyanin extracts. The extract of &lt;em&gt;Begonia rex-cultorum&lt;/em&gt; &amp;lsquo;Baby rainbow&amp;rsquo; exhibited significant cytotoxic activity against all tumor cell lines than &lt;em&gt;Begonia malabarica&lt;/em&gt; extract. &lt;em&gt;Begonia malabarica&lt;/em&gt; and &lt;em&gt;Begonia rex-cultorum&lt;/em&gt; &amp;lsquo;Baby rainbow&amp;rsquo; anthocyanin extract exhibited the highest cytotoxicity towards HT29 and HeLa cell lines respectively. But, MG63 resulted in comparatively higher percentage of viability of cell lines at the same concentrations. The anthocyanin extract produced significant morphological alterations on cell lines in culture. Meanwhile, the extracts showed poor cytotoxicity against the normal cell line. &lt;strong&gt;Conclusion:&lt;/strong&gt; The morphological alteration of the treated cancer cells presented clear evidence of significant cytotoxicity of anthocyanin extracts of both Begonias in all the three cell lines. Thus, anthocyanin may act as chemopreventive agents for various cancer cell lines.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">553</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Aswathy Jayasree Madanakumar, Murugan Kumaraswamy&lt;sup&gt;* &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;Plant Biochemistry and Molecular Biology Laboratory, Department of Botany, University College, Trivandrum, 695 034, Kerala, INDIA.&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alexander Victory</style></author><author><style face="normal" font="default" size="100%">Rezi Riadhi Syahdi</style></author><author><style face="normal" font="default" size="100%">Arry Yanuar</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Virtual Screening of Indonesian Herbal Database as Murine Double Minute-2 (MDM2) Inhibitor</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Cancer</style></keyword><keyword><style  face="normal" font="default" size="100%">Docking</style></keyword><keyword><style  face="normal" font="default" size="100%">Indonesian Herbal</style></keyword><keyword><style  face="normal" font="default" size="100%">Inhibitor</style></keyword><keyword><style  face="normal" font="default" size="100%">MDM2</style></keyword><keyword><style  face="normal" font="default" size="100%">Virtual Screening</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style  face="normal" font="default" size="100%">August 2018</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">10</style></volume><pages><style face="normal" font="default" size="100%">1184-1189</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Murine Double Minute-2 (MDM2) overexpression causes the p53 deficiency, so the role p53 as a cell regulator does not work in the case of cancer. &lt;strong&gt;Methods:&lt;/strong&gt; In this study, virtual screening of Indonesian herbal database to discover MDM2 inhibitors was carried out. Autodock and Autodock Vina validated with Directory of Useful Decoy-Enhanced (DUD-E). Validation parameters were performed with Enrichment Factor, Receiver Operating Characteristics, and Area Under Curve. &lt;strong&gt;Results:&lt;/strong&gt; The validation with the grid box 70x70x70 on Autodock resulting AUC value 0.72, while in Autodock Vina 0.43. Autodock Vina did not fulfilll the standard value but still used for comparison. Based on the virtual screening result, top ten compounds from Autodock are Nimolicinol, Jacoumaric acid, Isoarborinol, Lantic acid, Diosgenin, Theasaponin E1, Taraxasterol, Leucadenone C, Simiarenol, and Alpha-Amyrin were found to have strong interaction with MDM2, with binding energy (&amp;Delta;G) ranging from -8.83 to -9.65 kcal/mol. The Autodock Vina screening resulted in the identification of Yuehchukene, Morusin, Cyanidin, Leucadenone C, Roxburghine-B, Ocidentoside, Beta-sitosterol, Curine, Withangulatin, and Jacoumaric acid as potential inhibitors with binding energy (&amp;Delta;G) ranging from -8.7 to -9.4 kcal/mol. &lt;strong&gt;Conclusion:&lt;/strong&gt; Jacoumaric acid and Leucadenone C were shown to interact with the active site in MDM2 at residues Leu54, Ile61, Met62, and Ile99.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">1184</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Alexander Victory, Rezi Riadhi Syahdi, Arry Yanuar*&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;Faculty of Pharmacy, Universitas Indonesia, 16424, Depok, INDONESIA.&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sonika Jain</style></author><author><style face="normal" font="default" size="100%">Jaya Dwivedi</style></author><author><style face="normal" font="default" size="100%">Pankaj Kumar Jain</style></author><author><style face="normal" font="default" size="100%">Swaha Satpathy</style></author><author><style face="normal" font="default" size="100%">Arjun Patra</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Medicinal Plants for Treatment of Cancer: A Brief Review</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Allopathic Drugs</style></keyword><keyword><style  face="normal" font="default" size="100%">Breast cancer</style></keyword><keyword><style  face="normal" font="default" size="100%">Cancer</style></keyword><keyword><style  face="normal" font="default" size="100%">Cancer Cell Lines.</style></keyword><keyword><style  face="normal" font="default" size="100%">Chemotherapy</style></keyword><keyword><style  face="normal" font="default" size="100%">Medicinal Plants.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2015</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">8</style></volume><pages><style face="normal" font="default" size="100%">87-102</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;Cancer is actually a group of many related diseases that all have to do with cells. Cancer cells are characterized by unregulated growth, as well as insufficient and inappropriate vascular supply. Moreover, a core of cells was subjected to micro environmental stress conditions, and has decreased apoptotic potential through genetic alterations, thereby resulting in resistance to apoptosis. Cancer is one of the major causes of death worldwide where the number of cancer patients is in continuous rise. Cancer is a major public problem whose estimated worldwide new incidence is about 6 million cases per year. It is the second major cause of deaths after cardiovascular diseases. Chemotherapy remains the principal mode of treatment for various cancers. A number of synthetic anticancer drugs are available in practice, but the side effects and the drug interactions are major drawbacks in its clinical utility. Most of the currently used chemotherapy drugs for cancers are known to develop resistance, exhibit non-selective toxicity against normal cells and restrict by dose-limiting side effects. Hence, cancer treatment and development of drugs for this disease remains a major clinical challenge. On the other hand, plants are an exceptionally viable source of biologically active natural products which may serve as commercially significant entities in themselves or which may provide lead structures for the development of modified derivatives possessing enhanced activity and/or reduced toxicity in traeatment of cancer. Herbal medicines are now attracting attention as potential sources of anticancer agents and are widely used due to availability of the materials, affordability, relatively cheap and little or no side effects, wide applicability and therapeutic efficacy which in turn has accelerated the scientific research. For these reasons, World Health Organization (WHO) supports the use of traditional medicines which are efficacious and non toxic. In this review we have summarized few plants having anticancer activity.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Review Article</style></work-type><section><style face="normal" font="default" size="100%">87</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Sonika Jain,&lt;sup&gt;1&lt;/sup&gt; Jaya Dwivedi&lt;sup&gt;1&lt;/sup&gt;, Pankaj Kumar Jain&lt;sup&gt;2&lt;/sup&gt;, Swaha Satpathy&lt;sup&gt;3&lt;/sup&gt; and Arjun Patra&lt;sup&gt;3*&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Chemistry, Banasthali Vidyapith, Rajasthan, INDIA.&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Pharmacy, Banasthali Vidyapith, Rajasthan, INDIA.&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Institute of Pharmacy, Guru Ghasidas Vishwavidyalaya, Bilaspur (C.G.), INDIA.&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&amp;nbsp;&lt;/p&gt;
</style></auth-address></record></records></xml>